Aurora Investment Counsel Invests $2.49 Million in Teleflex Incorporated (NYSE:TFX)

Aurora Investment Counsel acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 14,013 shares of the medical technology company’s stock, valued at approximately $2,494,000. Teleflex accounts for approximately 1.4% of Aurora Investment Counsel’s portfolio, making the stock its 19th largest position.

Other large investors have also recently bought and sold shares of the company. Avior Wealth Management LLC increased its holdings in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in Teleflex in the third quarter valued at about $40,000. True Wealth Design LLC increased its holdings in Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after acquiring an additional 217 shares during the period. Finally, Banque Cantonale Vaudoise boosted its stake in shares of Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock worth $56,000 after acquiring an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $136.04 on Friday. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.90. The business’s 50-day moving average price is $167.87 and its 200 day moving average price is $198.71. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $6.31 billion, a PE ratio of 27.04, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.00%. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on TFX shares. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Morgan Stanley cut their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research report on Wednesday, March 5th. Finally, Piper Sandler reiterated a “neutral” rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.